Variant report
Variant | esv1007948 |
---|---|
Chromosome Location | chr4:160484245-160492870 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RAPGEF2-5 | chr4:160485093-160485299 | expReg_chr4_8078_+ |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79627241 | chr4:160484308-160484309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545685317 | chr4:160484313-160484314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs979909 | chr4:160484376-160484377 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs575936221 | chr4:160484392-160484393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143548116 | chr4:160484395-160484396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371164609 | chr4:160484396-160484397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186217619 | chr4:160484415-160484416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138431879 | chr4:160484437-160484438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190692033 | chr4:160484461-160484462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559094624 | chr4:160484523-160484524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552785678 | chr4:160484566-160484567 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528275269 | chr4:160484574-160484575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572688958 | chr4:160484582-160484583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143891855 | chr4:160484598-160484599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571198250 | chr4:160484644-160484645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537396389 | chr4:160484703-160484704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147246076 | chr4:160484715-160484716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567288511 | chr4:160484743-160484744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535930218 | chr4:160484769-160484770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76968468 | chr4:160484782-160484783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573425963 | chr4:160484790-160484791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557533266 | chr4:160484797-160484798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533411404 | chr4:160484861-160484862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575828452 | chr4:160484902-160484903 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs56336757 | chr4:160484905-160484906 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs561094034 | chr4:160484914-160484915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574798523 | chr4:160484916-160484917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370721559 | chr4:160484928-160484929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73859188 | chr4:160484947-160484948 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs560223254 | chr4:160484987-160484988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532511896 | chr4:160485003-160485004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374878232 | chr4:160485008-160485009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11321530 | chr4:160485095-160485096 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs397995978 | chr4:160485102-160485103 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs201057696 | chr4:160485103-160485104 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs551157752 | chr4:160485115-160485116 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs141585050 | chr4:160485116-160485117 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs11944945 | chr4:160485140-160485141 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs139399676 | chr4:160485144-160485145 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs567120245 | chr4:160485160-160485161 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs368045715 | chr4:160485204-160485205 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs371811217 | chr4:160485243-160485244 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs546676719 | chr4:160485310-160485311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180737687 | chr4:160485342-160485343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4691576 | chr4:160485391-160485392 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs559182323 | chr4:160485404-160485405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368735851 | chr4:160485412-160485413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11945017 | chr4:160485488-160485489 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs538129336 | chr4:160485545-160485546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112547168 | chr4:160485582-160485583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19805367 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:160479600-160506800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr4:160484200-160484400 | Enhancers | Fetal Intestine Small | intestine |
3 | chr4:160484200-160486400 | Enhancers | Fetal Intestine Large | intestine |
4 | chr4:160484600-160486000 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr4:160485200-160485400 | Enhancers | Pancreas | Pancrea |
6 | chr4:160485400-160486200 | Weak transcription | Pancreas | Pancrea |
7 | chr4:160485400-160486400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
8 | chr4:160485600-160486000 | Active TSS | Rectal Mucosa Donor 29 | rectum |
9 | chr4:160486000-160486200 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
10 | chr4:160486000-160486400 | Enhancers | Liver | Liver |
11 | chr4:160486000-160486400 | Enhancers | Fetal Intestine Small | intestine |
12 | chr4:160486200-160486400 | Enhancers | Pancreas | Pancrea |
13 | chr4:160486400-160487200 | Weak transcription | Pancreas | Pancrea |
14 | chr4:160487200-160487400 | Enhancers | Pancreas | Pancrea |